Ameritas Investment Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,757
Closed -$1.43M 3107
2021
Q2
$1.43M Buy
7,757
+107
+1% +$19.7K 0.05% 459
2021
Q1
$1.17M Sell
7,650
-80
-1% -$12.2K 0.04% 536
2020
Q4
$1.21M Buy
7,730
+80
+1% +$12.5K 0.06% 455
2020
Q3
$875K Sell
7,650
-370
-5% -$42.3K 0.04% 521
2020
Q2
$900K Hold
8,020
0.04% 495
2020
Q1
$720K Sell
8,020
-198
-2% -$17.8K 0.04% 496
2019
Q4
$889K Buy
8,218
+205
+3% +$22.2K 0.04% 569
2019
Q3
$785K Sell
8,013
-125
-2% -$12.2K 0.04% 594
2019
Q2
$1.07M Buy
8,138
+85
+1% +$11.1K 0.05% 484
2019
Q1
$1.09M Buy
8,053
+30
+0.4% +$4.06K 0.05% 471
2018
Q4
$781K Buy
8,023
+96
+1% +$9.35K 0.04% 556
2018
Q3
$1.1M Sell
7,927
-274
-3% -$38.1K 0.05% 494
2018
Q2
$1.02M Sell
8,201
-400
-5% -$49.7K 0.05% 529
2018
Q1
$959K Sell
8,601
-352
-4% -$39.2K 0.05% 534
2017
Q4
$1.07M Sell
8,953
-241
-3% -$28.8K 0.05% 519
2017
Q3
$1.31M Hold
9,194
0.06% 408
2017
Q2
$1.12M Hold
9,194
0.05% 483
2017
Q1
$1.12M Sell
9,194
-194
-2% -$23.5K 0.06% 467
2016
Q4
$1.15M Hold
9,388
0.06% 449
2016
Q3
$1.15M Buy
9,388
+1,005
+12% +$123K 0.06% 417
2016
Q2
$979K Buy
8,383
+358
+4% +$41.8K 0.06% 307
2016
Q1
$1.12M Sell
8,025
-1,638
-17% -$228K 0.07% 266
2015
Q4
$1.84M Sell
9,663
-9,572
-50% -$1.83M 0.12% 177
2015
Q3
$3.01M Buy
19,235
+415
+2% +$64.9K 0.22% 89
2015
Q2
$3.4M Buy
18,820
+1,596
+9% +$288K 0.22% 88
2015
Q1
$2.98M Buy
17,224
+1,837
+12% +$318K 0.2% 109
2014
Q4
$2.85M Buy
15,387
+22
+0.1% +$4.07K 0.2% 113
2014
Q3
$2.55M Sell
15,365
-445
-3% -$73.8K 0.18% 124
2014
Q2
$2.47M Sell
15,810
-298
-2% -$46.6K 0.18% 128
2014
Q1
$2.45M Sell
16,108
-243
-1% -$37K 0.19% 124
2013
Q4
$2.17M Buy
16,351
+3,799
+30% +$505K 0.17% 144
2013
Q3
$1.46M Buy
12,552
+4,152
+49% +$482K 0.14% 199
2013
Q2
$775K Buy
+8,400
New +$775K 0.21% 184